Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Solid Biosciences Inc. (SLDB)
USD9.72
-0.70 (-6.72%)
US NASDAQ Healthcare Biotechnology
Address
141 Portland Street 2139
Cambridge, MA, US
Cambridge, MA, US
CEO
Alexander G. Cumbo
Website
solidbio.com
IPO
2018-01-26
CIK 1707502 ISIN US83422E2046
Description
Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD9.72
-0.70 (-6.72%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
2.43
Float Shares
59.92M
Free Float %
76.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.82% | +8.58% | +1.10% | +18.20% | +35.17% | +30.14% | +107.34% | +18.77% | -86.95% | -97.84% | -97.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (21 ratings, all time)
Buy
Price Targets & DCF
Current price
9.72
Low
16.00
+64.6%
Consensus
16.67
+71.5%
Median
16.00
+64.6%
High
18.00
+85.2%
DCF (Unlevered)
0.41
-95.8%
DCF (Levered)
0.44
-95.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 10 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
17.00
+74.9%
|
| Last Quarter | 2 |
17.00
+74.9%
|
| Last Year | 5 |
15.00
+54.3%
|
| All Time | 9 |
16.11
+65.7%
|
Quality scores
Altman Z-Score
2.96
Grey zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+35.0% ★ Q1'26: +11.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-1,345.3% Q1'26: -1,700.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+114.4% Q1'26: +65.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.12× Q1'26: -0.09× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 10 EPS Ana. |
Dec 2027 8 Rev. Ana. 10 EPS Ana. |
Dec 2028 8 Rev. Ana. 6 EPS Ana. |
Dec 2029 7 Rev. Ana. 4 EPS Ana. |
Dec 2030 7 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.62M
est: 12.10M (+12.6%)
|
8.09M
est: 8.10M (0.0%)
|
—
est: 1.10M (-100.0%)
|
—
est: 1.21M (-100.0%)
|
—
est: 1.49M (-100.0%)
|
3.68M
1.22M – 6.14M
+147.4% YoY
|
14.78M
4.89M – 24.66M
+301.6% YoY
|
127.62M
42.26M – 212.96M
+763.6% YoY
|
279.56M
92.56M – 466.50M
+119.1% YoY
|
456.29M
151.08M – 761.42M
+63.2% YoY
|
| EBITDA |
-69.29M
est: 2.42M (-2,963.5%)
|
-96.87M
est: 1.62M (-6,080.9%)
|
-93.43M
est: 220.0K (-42,570.2%)
|
-121.90M
est: 242.8K (-50,302.8%)
|
-177.57M
est: 297.5K (-59,796.6%)
|
736.0K
243.7K – 1.23M
+147.4% YoY
|
2.96M
978.6K – 4.93M
+301.6% YoY
|
25.52M
8.45M – 42.59M
+763.6% YoY
|
55.91M
18.51M – 93.30M
+119.1% YoY
|
91.26M
30.22M – 152.28M
+63.2% YoY
|
| EBIT |
-72.25M
est: 2.42M (-3,086.0%)
|
-99.27M
est: 1.62M (-6,229.5%)
|
-96.02M
est: 220.0K (-43,743.4%)
|
-124.36M
est: 242.8K (-51,313.9%)
|
-179.21M
est: 297.5K (-60,346.6%)
|
736.0K
243.7K – 1.23M
+147.4% YoY
|
2.96M
978.6K – 4.93M
+301.6% YoY
|
25.52M
8.45M – 42.59M
+763.6% YoY
|
55.91M
18.51M – 93.30M
+119.1% YoY
|
91.26M
30.22M – 152.28M
+63.2% YoY
|
| Net Income |
-72.19M
est: -439.60M (+83.6%)
|
-85.98M
est: -278.73M (+69.2%)
|
-96.02M
est: -194.36M (+50.6%)
|
-124.70M
est: -254.76M (+51.1%)
|
-174.33M
est: -191.78M (+9.1%)
|
-162.65M
-193.15M – -132.15M
+15.2% YoY
|
-158.28M
-211.04M – -105.52M
+2.7% YoY
|
-154.83M
-167.21M – -43.79M
+2.2% YoY
|
6.85M
894.0K – 12.81M
+104.4% YoY
|
99.61M
12.99M – 186.20M
+1,353.2% YoY
|
| SGA |
27.14M
est: 20.73M (+30.9%)
|
28.95M
est: 13.88M (+108.6%)
|
27.75M
est: 1.89M (+1,372.2%)
|
33.30M
est: 2.08M (+1,500.3%)
|
38.88M
est: 2.55M (+1,425.5%)
|
6.31M
2.09M – 10.52M
+147.4% YoY
|
25.33M
8.39M – 42.26M
+301.6% YoY
|
218.71M
72.42M – 364.96M
+763.6% YoY
|
479.10M
158.63M – 799.47M
+119.1% YoY
|
781.98M
258.91M – 1.30B
+63.2% YoY
|
| EPS |
-10.14
est: -10.77 (+5.8%)
|
-10.10
est: -6.83 (-47.9%)
|
-4.83
est: -4.76 (-1.4%)
|
-3.06
est: -2.94 (-4.2%)
|
-1.99
est: -2.12 (+5.9%)
|
-1.91
-2.21 – -1.51
+9.7% YoY
|
-1.90
-2.41 – -1.21
+0.6% YoY
|
-1.24
-1.91 – -0.50
+34.5% YoY
|
0.08
0.01 – 0.15
+106.3% YoY
|
1.14
0.15 – 2.13
+1,353.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-18 | Wedbush | Outperform | Outperform | Maintain |
| 2026-05-13 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-171.67M
OE per share TTM
-1.75
Owner's Yield
-21.30%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
750.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
147
Total invested
717.40M
Insider transactions (90d)
0
Beneficial owners (>5%)
44
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 9.20M | 11.00% | — | 9.20M | — | 9.20M | IA, OO | Delaware | 2022-02-14 | ↗ |
| 2 | Oleg Nodelman | 9.20M | 11.00% | — | 9.20M | — | 9.20M | HC, IN | United States | 2022-02-14 | ↗ |
| 3 | EcoR1 Capital Fund Qualified, L.P. | 8.37M | 11.00% | — | 8.37M | — | 8.37M | PN | Delaware | 2022-02-14 | ↗ |
| 4 | Ultragenyx Pharmaceutical Inc. | 7.83M | 14.50% | 7.83M | — | 7.83M | 11.00 | CO | — | 2020-11-06 | ↗ |
| 5 | Aaron Cowen | 5.97M | 5.40% | — | 5.97M | — | 5.97M | HC, IN | Delaware | 2021-03-29 | ↗ |
| 6 | Averill Master Fund, Ltd. | 5.97M | 5.40% | — | 5.97M | — | 5.97M | CO | Delaware | 2021-03-29 | ↗ |
| 7 | Suvretta Capital Management, LLC | 5.97M | 5.40% | — | 5.97M | — | 5.97M | IA, OO | Delaware | 2021-03-29 | ↗ |
| 8 | K2 & ASSOCIATES INVESTMENT MANAGEMENT INC. | 5.71M | 5.05% | — | 5.71M | — | 5.71M | CO | ONTARIO, CANADA | 2022-09-01 | ↗ |
| 9 | K2 Genpar 2017 Inc. | 5.71M | 5.05% | — | 5.71M | — | 5.71M | CO | Ontario, CANADA | 2022-09-01 | ↗ |
| 10 | L.P. | 5.71M | 5.05% | — | 5.71M | — | 5.71M | PN | Ontario, CANADA | 2022-09-01 | ↗ |
| 11 | SHAWN KIMEL INVESTMENTS, INC. | 5.71M | 5.05% | — | 5.71M | — | 5.71M | CO | ONTARIO, CANADA | 2022-09-01 | ↗ |
| 12 | Boxer Asset Management Inc. | 5.34M | 4.70% | — | 5.34M | — | 5.34M | CO | — | 2022-02-14 | ↗ |
| 13 | Boxer Capital, LLC | 5.34M | 4.70% | — | 5.34M | — | 5.34M | OO | — | 2022-02-14 | ↗ |
| 14 | Joe Lewis | 5.34M | 4.70% | — | 5.34M | — | 5.34M | IN | — | 2022-02-14 | ↗ |
| 15 | (1) BlackRock, Inc. | 2.87M | 2.50% | 2.74M | — | 2.87M | — | HC | Delaware | 2022-07-08 | ↗ |
| 16 | Ryan Wilder | 2.80M | 7.30% | — | 2.80M | — | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 17 | Vestal Point Capital, LP | 2.80M | 7.30% | — | 2.80M | — | — | IA, PN | Delaware | 2024-11-14 | ↗ |
| 18 | Artal Group S.A. | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 19 | Artal International Management S.A. | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 20 | Artal International S.C.A. | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 21 | Invus Public Equities Advisors, LLC | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 22 | Invus Public Equities, L.P. | 2.72M | 7.30% | 2.72M | — | 2.72M | — | PN | Luxembourg | 2024-01-22 | ↗ |
| 23 | Mr. Amaury Wittouck | 2.72M | 7.30% | 2.72M | — | 2.72M | — | IN | Luxembourg | 2024-01-22 | ↗ |
| 24 | Stichting Administratiekantoor Westend | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 25 | Westend S.A. | 2.72M | 7.30% | 2.72M | — | 2.72M | — | OO | Luxembourg | 2024-01-22 | ↗ |
| 26 | Adage Capital Management, L.P. | 2.71M | 7.25% | — | 2.71M | — | — | IA, PN | Delaware | 2024-02-07 | ↗ |
| 27 | Adage Capital Partners GP, L.L.C. | 2.71M | 7.25% | — | 2.71M | — | — | OO | Delaware | 2024-02-07 | ↗ |
| 28 | Adage Capital Partners, L.P. | 2.71M | 7.25% | — | 2.71M | — | — | PN | Delaware | 2024-02-07 | ↗ |
| 29 | Phillip Gross | 2.71M | 7.25% | — | 2.71M | — | — | IN | United States | 2024-02-07 | ↗ |
| 30 | Robert Atchinson | 2.71M | 7.25% | — | 2.71M | — | — | IN | United States | 2024-02-07 | ↗ |
| 31 | BCLS II Investco, LP | 2.30M | 11.80% | — | 2.30M | — | 2.30M | PN | — | 2022-12-05 | ↗ |
| 32 | Deerfield Management Company, L.P. | 2.26M | 6.08% | — | 2.26M | — | — | PN | United States | 2024-01-12 | ↗ |
| 33 | Deerfield Mgmt, L.P. | 2.26M | 6.08% | — | 2.26M | — | — | PN | United States | 2024-01-12 | ↗ |
| 34 | Deerfield Partners, L.P. | 2.26M | 6.08% | — | 2.26M | — | — | PN | United States | 2024-01-12 | ↗ |
| 35 | James E. Flynn | 2.26M | 6.08% | — | 2.26M | — | — | IN | United States | 2024-01-12 | ↗ |
| 36 | Israel A. Englander | 2.01M | 5.20% | — | 2.01M | — | 2.01M | IN | Delaware | 2024-06-05 | ↗ |
| 37 | Millennium Group Management LLC | 2.01M | 5.20% | — | 2.01M | — | 2.01M | OO | Delaware | 2024-06-05 | ↗ |
| 38 | Millennium Management LLC | 2.01M | 5.20% | — | 2.01M | — | 2.01M | OO | Delaware | 2024-06-05 | ↗ |
| 39 | BCLS SB Investco, LP | 528.7K | 2.70% | — | 528.7K | — | 528.7K | PN | — | 2022-12-05 | ↗ |
| 40 | Bain Capital Life Sciences Fund II, L.P. | 267.3K | 1.40% | — | 267.3K | — | 267.3K | PN | — | 2022-12-05 | ↗ |
| 41 | BCIP Life Sciences Associates, LP | 32.6K | 0.20% | — | 32.6K | — | 32.6K | PN | — | 2022-12-05 | ↗ |
| 42 | Stephen DuBois Not applicable | 2.0K | 7.26% | — | 1.42M | — | 1.42M | IN | Delaware | 2022-12-12 | ↗ |
| 43 | Aaron I. Davis | — | 0.00% | — | — | — | — | IN | — | 2022-02-14 | ↗ |
| 44 | MVA Investors, LLC | — | 0.00% | — | — | — | — | OO | — | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
147
+18 vs prev Q
New positions
31
Closed positions
15
Increased
83
Reduced
40
Put/Call ratio
0.47
Calls held
301.1K
Puts held
142.5K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 11.83M +— (+0.0%) | 66.74M -6.3M (-8.6%) | 12.53% -0.037 pp | 1.19% -0.919 pp | USD6.70 -15.8% | 13 qtrs — |
| 2 | BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 7.91M +— (+0.0%) | 44.62M -4.2M (-8.6%) | 8.38% -0.025 pp | 3.42% +0.178 pp | USD5.36 +5.2% | 13 qtrs — |
| 3 | SIREN, L.L.C. | 7.69M +274.5K (+3.7%) | 43.37M -2.4M (-5.2%) | 8.15% +0.268 pp | 1.29% -0.496 pp | USD4.98 +13.3% | 6 qtrs — |
| 4 | VESTAL POINT CAPITAL, LP | 5.82M +2.8M (+95.5%) | 32.80M +14.4M (+78.7%) | 6.16% +2.999 pp | 1.12% +0.286 pp | USD6.50 -13.2% | 9 qtrs — |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 5.81M +— (+0.0%) | 32.78M -3.1M (-8.6%) | 6.16% -0.018 pp | 0.34% -0.106 pp | USD6.35 -11.2% | 13 qtrs — |
| 6 | BLACKROCK, INC. | 4.87M +144.6K (+3.1%) | 27.47M -1.7M (-5.8%) | 5.16% +0.138 pp | 0.00% +0.000 pp | USD5.45 +3.5% | 6 qtrs — |
| 7 | VANGUARD GROUP INC | 3.45M +371.1K (+12.0%) | 19.49M +458.6K (+2.4%) | 3.66% +0.384 pp | 0.00% +0.000 pp | USD6.57 -14.2% | 13 qtrs — |
| 8 | CITADEL ADVISORS LLC | 2.66M +71.2K (+2.7%) | 15.02M -972.8K (-6.1%) | 2.82% +0.067 pp | 0.00% 0.000 pp | USD5.28 +6.8% | 8 qtrs — |
| 9 | ARMISTICE CAPITAL, LLC | 2.61M +1.7M (+179.1%) | 14.73M +9.0M (+155.1%) | 2.77% +1.772 pp | 0.18% +0.090 pp | USD5.63 +0.2% | 3 qtrs — |
| 10 | POINT72 ASSET MANAGEMENT, L.P. | 2.42M +1.1M (+81.3%) | 13.63M +5.4M (+65.7%) | 2.56% +1.143 pp | 0.02% +0.002 pp | USD5.15 +9.5% | 7 qtrs — |
| 11 | FMR LLC | 2.03M -884.2K (-30.3%) | 11.45M -6.5M (-36.3%) | 2.15% -0.946 pp | 0.00% 0.000 pp | USD3.74 +50.8% | 6 qtrs — |
| 12 | REDMILE GROUP, LLC | 1.86M -38.8K (-2.0%) | 10.49M -1.2M (-10.5%) | 1.97% -0.047 pp | 0.77% -0.367 pp | USD3.79 +48.8% | 5 qtrs — |
| 13 | ALYESKA INVESTMENT GROUP, L.P. | 1.68M +— (+0.0%) | 9.49M -891.9K (-8.6%) | 1.78% -0.005 pp | 0.03% -0.005 pp | USD4.10 +37.6% | 13 qtrs — |
| 14 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.60M -95.9K (-5.6%) | 9.04M -1.4M (-13.8%) | 1.70% -0.107 pp | 0.30% -0.065 pp | USD4.68 +20.5% | 4 qtrs — |
| 15 | FRANKLIN RESOURCES INC | 1.60M +1.0 (+0.0%) | 9.02M -847.6K (-8.6%) | 1.69% -0.005 pp | 0.00% 0.000 pp | USD3.96 +42.4% | 4 qtrs — |
| 16 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.40M -2.6M (-65.0%) | 7.90M -16.8M (-68.0%) | 1.48% -2.766 pp | 0.01% -0.027 pp | USD5.97 -5.5% | 8 qtrs — |
| 17 | MONASHEE INVESTMENT MANAGEMENT LLC | 1.35M +1.3M (+100.0%) | 7.61M +7.6M (+100.0%) | 1.43% +1.430 pp | 4.29% +4.290 pp | USD5.64 +0.0% | 8 qtrs — |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 1.27M -19.9K (-1.5%) | 7.15M -794.4K (-10.0%) | 1.34% -0.025 pp | 0.00% 0.000 pp | USD5.82 -3.1% | 13 qtrs — |
| 19 | STATE STREET CORP | 1.09M -5.9K (-0.5%) | 6.13M -612.6K (-9.1%) | 1.15% -0.010 pp | 0.00% +0.000 pp | USD5.76 -2.1% | 13 qtrs — |
| 20 | GOLDMAN SACHS GROUP INC | 1.01M +329.7K (+48.7%) | 5.68M +1.5M (+35.9%) | 1.07% +0.347 pp | 0.00% +0.000 pp | USD5.92 -4.7% | 8 qtrs — |
| 21 | FINEPOINT CAPITAL LP | 961.3K +— (+0.0%) | 5.42M -509.5K (-8.6%) | 1.02% -0.003 pp | 0.27% -0.071 pp | USD5.13 +9.9% | 13 qtrs — |
| 22 | UBS GROUP AG | 911.4K +187.3K (+25.9%) | 5.14M +672.4K (+15.0%) | 0.97% +0.196 pp | 0.00% +0.000 pp | USD4.98 +13.3% | 13 qtrs — |
| 23 | BIRCHVIEW CAPITAL, LP | 706.0K +409.0K (+137.7%) | 3.98M +2.1M (+117.3%) | 0.75% +0.432 pp | 2.33% +0.948 pp | USD5.32 +6.0% | 4 qtrs — |
| 24 | DIMENSIONAL FUND ADVISORS LP | 679.1K +235.5K (+53.1%) | 3.83M +1.1M (+40.0%) | 0.72% +0.248 pp | 0.00% +0.000 pp | USD5.53 +2.0% | 13 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 499.3K -4.4K (-0.9%) | 2.82M -291.6K (-9.4%) | 0.53% -0.006 pp | 0.00% +0.000 pp | USD5.31 +6.2% | 9 qtrs — |
| 26 | PARKMAN HEALTHCARE PARTNERS LLC | 418.4K +22.0K (+5.5%) | 2.36M -86.2K (-3.5%) | 0.44% +0.022 pp | 0.22% -0.031 pp | USD6.14 -8.1% | 2 qtrs — |
| 27 | ALLY BRIDGE GROUP (NY) LLC | 413.6K -135.6K (-24.7%) | 2.33M -1.1M (-31.2%) | 0.44% -0.145 pp | 2.43% +0.367 pp | USD4.87 +15.8% | 3 qtrs — |
| 28 | NORTHERN TRUST CORP | 412.8K -33.7K (-7.6%) | 2.33M -426.9K (-15.5%) | 0.44% -0.037 pp | 0.00% 0.000 pp | USD5.62 +0.4% | 12 qtrs — |
| 29 | NUVEEN, LLC | 395.0K +— (+0.0%) | 2.23M -209.3K (-8.6%) | 0.42% -0.001 pp | 0.00% 0.000 pp | USD4.74 +19.0% | 4 qtrs — |
| 30 | MORGAN STANLEY | 394.3K +136.4K (+52.9%) | 2.22M +632.7K (+39.8%) | 0.42% +0.144 pp | 0.00% +0.000 pp | USD4.99 +13.0% | 13 qtrs — |
| 31 | BALYASNY ASSET MANAGEMENT L.P. | 360.9K -371.7K (-50.7%) | 2.04M -2.5M (-55.0%) | 0.38% -0.396 pp | 0.00% -0.003 pp | USD4.53 +24.5% | 8 qtrs — |
| 32 | BANK OF AMERICA CORP /DE/ | 344.3K -445.7K (-56.4%) | 1.94M -2.9M (-60.2%) | 0.36% -0.475 pp | 0.00% 0.000 pp | USD4.94 +14.2% | 13 qtrs — |
| 33 | WOODLINE PARTNERS LP | 316.8K -315.0K (-49.9%) | 1.79M -2.1M (-54.2%) | 0.34% -0.336 pp | 0.01% -0.011 pp | USD3.70 +52.4% | 4 qtrs — |
| 34 | BOXER CAPITAL MANAGEMENT, LLC | 300.0K -300.0K (-50.0%) | 1.69M -2.0M (-54.3%) | 0.32% -0.320 pp | 0.37% -0.810 pp | USD6.17 -8.6% | 4 qtrs — |
| 35 | PANAGORA ASSET MANAGEMENT INC | 226.8K -170.4K (-42.9%) | 1.28M -1.2M (-47.8%) | 0.24% -0.182 pp | 0.00% -0.005 pp | USD6.17 -8.6% | 2 qtrs — |
| 36 | JANE STREET GROUP, LLC | 213.4K +121.8K (+133.0%) | 1.20M +638.5K (+113.0%) | 0.23% +0.129 pp | 0.00% +0.000 pp | USD5.87 -3.9% | 2 qtrs — |
| 37 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 199.4K +— (+0.0%) | 1.12M -105.7K (-8.6%) | 0.21% -0.001 pp | 0.02% -0.002 pp | USD4.77 +18.2% | 4 qtrs — |
| 38 | APIS CAPITAL ADVISORS, LLC | 196.0K +— (+0.0%) | 1.11M -103.9K (-8.6%) | 0.21% -0.001 pp | 0.19% -0.075 pp | USD4.23 +33.3% | 4 qtrs — |
| 39 | WELLINGTON MANAGEMENT GROUP LLP | 185.7K -40.7K (-18.0%) | 1.05M -349.6K (-25.0%) | 0.20% -0.044 pp | 0.00% 0.000 pp | USD5.39 +4.6% | 7 qtrs — |
| 40 | SCHONFELD STRATEGIC ADVISORS LLC | 182.9K +114.9K (+168.9%) | 1.03M +611.8K (+145.8%) | 0.19% +0.121 pp | 0.00% +0.002 pp | USD5.84 -3.4% | 2 qtrs — |
| 41 | KNOTT DAVID M JR | 162.4K +— (+0.0%) | 916.2K -86.1K (-8.6%) | 0.17% -0.001 pp | 0.42% +0.020 pp | USD3.92 +43.9% | 4 qtrs — |
| 42 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 161.5K -522.0 (-0.3%) | 911.1K -88.8K (-8.9%) | 0.17% -0.001 pp | 0.00% +0.000 pp | USD5.56 +1.4% | 8 qtrs — |
| 43 | IKARIAN CAPITAL, LLC | 160.4K -16.3K (-9.2%) | 904.7K -185.5K (-17.0%) | 0.17% -0.018 pp | 0.07% -0.039 pp | USD6.17 -8.6% | 4 qtrs — |
| 44 | TWO SIGMA INVESTMENTS, LP | 153.4K -2.4K (-1.6%) | 865.2K -96.4K (-10.0%) | 0.16% -0.003 pp | 0.00% 0.000 pp | USD6.05 -6.8% | 9 qtrs — |
| 45 | INVESCO LTD. | 152.1K +34.8K (+29.6%) | 858.0K +133.8K (+18.5%) | 0.16% +0.036 pp | 0.00% +0.000 pp | USD5.08 +11.0% | 8 qtrs — |
| 46 | BANK OF NEW YORK MELLON CORP | 144.7K -4.0K (-2.7%) | 816.1K -101.1K (-11.0%) | 0.15% -0.005 pp | 0.00% +0.000 pp | USD5.33 +5.8% | 7 qtrs — |
| 47 | BOOTHBAY FUND MANAGEMENT, LLC | 142.6K -44.0K (-23.6%) | 804.3K -347.1K (-30.1%) | 0.15% -0.047 pp | 0.01% -0.005 pp | USD6.17 -8.6% | 2 qtrs — |
| 48 | BARCLAYS PLC | 138.1K +75.3K (+119.8%) | 779.1K +341.0K (+77.8%) | 0.15% +0.080 pp | 0.00% +0.000 pp | USD5.53 +2.0% | 13 qtrs — |
| 49 | AQR CAPITAL MANAGEMENT LLC | 132.0K +900.0 (+0.7%) | 744.2K -64.4K (-8.0%) | 0.14% +0.001 pp | 0.00% 0.000 pp | USD3.88 +45.4% | 6 qtrs — |
| 50 | D. E. SHAW & CO., INC. | 128.3K +128.3K (+100.0%) | 723.4K +723.4K (+100.0%) | 0.14% +0.136 pp | 0.00% +0.000 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 51 | MILLENNIUM MANAGEMENT LLC | 116.6K -793.1K (-87.2%) | 657.8K -5.0M (-88.3%) | 0.12% -0.843 pp | 0.00% -0.002 pp | USD6.82 -17.3% | 8 qtrs — |
| 52 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 116.5K +— (+0.0%) | 657.2K -61.8K (-8.6%) | 0.12% 0.000 pp | 0.02% -0.006 pp | USD3.70 +52.4% | 4 qtrs — |
| 53 | FISHER ASSET MANAGEMENT, LLC | 103.5K +103.5K (+100.0%) | 583.6K +583.6K (+100.0%) | 0.11% +0.110 pp | 0.00% +0.000 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 54 | AMERICAN CENTURY COMPANIES INC | 97.3K +26.3K (+37.0%) | 548.9K +110.5K (+25.2%) | 0.10% +0.028 pp | 0.00% +0.000 pp | USD6.35 -11.2% | 8 qtrs — |
| 55 | QUANTUM PRIVATE WEALTH, LLC | 94.2K +— (+0.0%) | 531.5K -49.9K (-8.6%) | 0.10% 0.000 pp | 0.16% -0.015 pp | USD5.22 +8.0% | 6 qtrs — |
| 56 | RHUMBLINE ADVISERS | 82.6K -11.7K (-12.4%) | 465.7K -116.0K (-19.9%) | 0.09% -0.013 pp | 0.00% 0.000 pp | USD5.36 +5.2% | 7 qtrs — |
| 57 | ALLIANCEBERNSTEIN L.P. | 81.8K +— (+0.0%) | 461.5K -43.4K (-8.6%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD5.14 +9.7% | 7 qtrs — |
| 58 | WELLS FARGO & COMPANY/MN | 76.1K +30.9K (+68.4%) | 429.2K +150.3K (+53.9%) | 0.08% +0.033 pp | 0.00% +0.000 pp | USD5.38 +4.8% | 13 qtrs — |
| 59 | BNP PARIBAS ARBITRAGE, SNC | 74.6K +1.6K (+2.2%) | 420.9K -29.7K (-6.6%) | 0.08% +0.002 pp | 0.00% +0.000 pp | USD5.83 -3.3% | 5 qtrs — |
| 60 | SIMPLEX TRADING, LLC | 60.5K -23.5K (-27.9%) | 341.4K -176.6K (-34.1%) | 0.06% -0.025 pp | 0.00% 0.000 pp | USD6.17 -8.6% | 9 qtrs — |
| 61 | RENAISSANCE TECHNOLOGIES LLC | 52.8K -410.9K (-88.6%) | 297.8K -2.6M (-89.6%) | 0.06% -0.437 pp | 0.00% -0.003 pp | USD6.17 -8.6% | 13 qtrs — |
| 62 | SQUAREPOINT OPS LLC | 50.1K +50.1K (+100.0%) | 282.3K +282.3K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 63 | DEUTSCHE BANK AG\ | 40.0K -12.2K (-23.4%) | 225.4K -96.4K (-30.0%) | 0.04% -0.013 pp | 0.00% +0.000 pp | USD5.38 +4.8% | 7 qtrs — |
| 64 | Y-INTERCEPT (HONG KONG) LTD | 36.1K +36.1K (+100.0%) | 203.9K +203.9K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.005 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 65 | XTX TOPCO LTD | 35.6K +35.6K (+100.0%) | 201.0K +201.0K (+100.0%) | 0.04% +0.038 pp | 0.01% +0.005 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 66 | PRICE T ROWE ASSOCIATES INC /MD/ | 35.1K +— (+0.0%) | 198.0K -19.0K (-8.8%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD4.56 +23.7% | 4 qtrs — |
| 67 | INTECH INVESTMENT MANAGEMENT LLC | 34.5K +4.5K (+15.2%) | 194.5K +9.7K (+5.3%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD4.55 +24.0% | 5 qtrs — |
| 68 | JPMORGAN CHASE & CO | 31.8K -3.9K (-11.1%) | 179.1K -41.2K (-18.7%) | 0.03% -0.004 pp | 0.00% +0.000 pp | USD4.56 +23.7% | 13 qtrs — |
| 69 | CIBC PRIVATE WEALTH GROUP, LLC | 30.6K +— (+0.0%) | 172.6K -16.2K (-8.6%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD3.70 +52.4% | 4 qtrs — |
| 70 | STATE OF WISCONSIN INVESTMENT BOARD | 30.0K -17.0K (-36.2%) | 169.2K -120.7K (-41.6%) | 0.03% -0.018 pp | 0.00% 0.000 pp | USD6.17 -8.6% | 2 qtrs — |
| 71 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 27.3K -48.0 (-0.2%) | 154.2K -14.8K (-8.8%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD5.56 +1.4% | 6 qtrs — |
| 72 | FOX RUN MANAGEMENT, L.L.C. | 25.0K +6.5K (+35.1%) | 141.0K +26.8K (+23.5%) | 0.03% +0.007 pp | 0.02% +0.004 pp | USD6.03 -6.5% | 6 qtrs — |
| 73 | CREATIVE PLANNING | 24.9K +8.6K (+52.6%) | 140.4K +39.7K (+39.4%) | 0.03% +0.009 pp | 0.00% +0.000 pp | USD5.37 +5.0% | 3 qtrs — |
| 74 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23.5K -15.0K (-39.0%) | 132.3K -105.0K (-44.2%) | 0.02% -0.016 pp | 0.00% -0.002 pp | USD4.51 +25.1% | 13 qtrs — |
| 75 | HSBC HOLDINGS PLC | 22.2K -1.4K (-6.1%) | 126.7K -11.5K (-8.4%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD6.15 -8.3% | 6 qtrs — |
| 76 | LIDO ADVISORS, LLC | 20.2K +— (+0.0%) | 124.5K +— (+0.0%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD3.70 +52.4% | 4 qtrs — |
| 77 | SG AMERICAS SECURITIES, LLC | 20.9K +20.9K (+100.0%) | 118.0K +118.0K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD5.64 +0.0% | 3 qtrs — |
| 78 | AXQ CAPITAL, LP | 20.6K -3.4K (-14.1%) | 116.4K -31.8K (-21.5%) | 0.02% -0.004 pp | 0.03% -0.031 pp | USD6.17 -8.6% | 2 qtrs — |
| 79 | JAIN GLOBAL LLC | 20.3K +20.3K (+100.0%) | 114.3K +114.3K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.001 pp | USD5.64 +0.0% | 1 qtrs NEW |
| 80 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 18.3K -4.2K (-18.8%) | 102.9K -35.8K (-25.8%) | 0.02% -0.005 pp | 0.00% +0.000 pp | USD4.87 +15.8% | 6 qtrs — |
| 81 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 17.4K +— (+0.0%) | 98.1K -9.2K (-8.6%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD4.81 +17.3% | 5 qtrs — |
| 82 | HRT FINANCIAL LP | 14.9K -141.9K (-90.5%) | 84.0K -883.0K (-91.3%) | 0.02% -0.151 pp | 0.00% -0.003 pp | USD6.17 -8.6% | 4 qtrs — |
| 83 | PROSHARE ADVISORS LLC | 14.2K +1.4K (+10.6%) | 80.2K +867.0 (+1.1%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD4.94 +14.2% | 3 qtrs — |
| 84 | SEI INVESTMENTS CO | 13.1K +— (+0.0%) | 73.8K -6.9K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD4.00 +41.0% | 5 qtrs — |
| 85 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 12.7K -954.0 (-7.0%) | 71.6K -12.6K (-15.0%) | 0.01% -0.001 pp | 0.01% -0.002 pp | USD3.88 +45.4% | 5 qtrs — |
| 86 | VOYA INVESTMENT MANAGEMENT LLC | 11.2K +— (+0.0%) | 62.9K -5.9K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD4.87 +15.8% | 3 qtrs — |
| 87 | COMMONWEALTH EQUITY SERVICES, LLC | 10.9K +— (+0.0%) | 61.2K -5.8K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.17 -8.6% | 2 qtrs — |
| 88 | TOWER RESEARCH CAPITAL LLC (TRC) | 10.7K +3.7K (+52.4%) | 60.2K +17.0K (+39.3%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD4.76 +18.5% | 13 qtrs — |
| 89 | MARTINGALE ASSET MANAGEMENT L P | 10.6K +346.0 (+3.4%) | 59.6K -3.5K (-5.5%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD4.90 +15.1% | 3 qtrs — |
| 90 | RUSSELL INVESTMENTS GROUP, LTD. | 7.2K -3.0K (-29.4%) | 40.6K -22.4K (-35.5%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD5.36 +5.2% | 4 qtrs — |
| 91 | NEW YORK STATE COMMON RETIREMENT FUND | 7.1K +— (+0.0%) | 40.0K -3.8K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.27 -10.0% | 7 qtrs — |
| 92 | GROUP ONE TRADING, L.P. | 6.6K +1.8K (+38.0%) | 37.0K +7.7K (+26.1%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD6.02 -6.3% | 6 qtrs — |
| 93 | LEGAL & GENERAL GROUP PLC | 5.3K +— (+0.0%) | 29.7K -2.8K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.32 +6.0% | 7 qtrs — |
| 94 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 5.0K +— (+0.0%) | 27.9K -2.6K (-8.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.37 -11.5% | 6 qtrs — |
| 95 | AMERITAS INVESTMENT PARTNERS, INC. | 4.9K +— (+0.0%) | 27.8K -2.6K (-8.6%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD5.33 +5.8% | 7 qtrs — |
| 96 | ACADIAN ASSET MANAGEMENT LLC | 5.0K +5.0K (+100.0%) | 27.0K +27.0K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD5.64 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.00
Neutral
Buys
1
Sells
1
Shares acquired
3.4K
Shares disposed
3.4K
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | SMITH IAN F | Director | M-Exempt | D | Restricted Stock Units | 3,441 | 0.00 | — | 10,320 | D | ↗ |
| 2026-03-09 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | A-Award | A | Pre-Funded Warrant (right to buy) | 8,912,655 | 0.00 | 8.9K | 8,912,655 | I | ↗ |
| 2026-02-18 | Tan Kevin | Officer | S-Sale | D | Common Stock | 5,404 | 5.82 | 31.5K | 99,422 | D | ↗ |
| 2026-02-18 | Howton David T | Officer | S-Sale | D | Common Stock | 7,469 | 5.82 | 43.5K | 105,077 | D | ↗ |
| 2026-02-18 | Herzich Paul | Officer | S-Sale | D | Common Stock | 3,616 | 5.82 | 21.1K | 72,638 | D | ↗ |
| 2026-02-18 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 4,134 | 5.82 | 24.1K | 74,318 | D | ↗ |
| 2026-02-18 | Ganot Ilan | Director | S-Sale | D | Common Stock | 2,658 | 5.82 | 15.5K | 27,474 | I | ↗ |
| 2026-02-18 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 16,644 | 5.82 | 96.9K | 235,405 | D | ↗ |
| 2026-02-18 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 0 | 5.82 | — | 89,466 | D | ↗ |
| 2026-02-13 | Tan Kevin | Officer | M-Exempt | A | Common Stock | 10,625 | 0.00 | — | 104,826 | D | ↗ |
| 2026-02-13 | Howton David T | Officer | M-Exempt | D | Restricted Stock Units | 14,687 | 0.00 | — | 29,376 | D | ↗ |
| 2026-02-13 | Herzich Paul | Officer | M-Exempt | D | Restricted Stock Units | 7,187 | 0.00 | — | 14,376 | D | ↗ |
| 2026-02-13 | Hanrahan Jessie | Officer | M-Exempt | A | Common Stock | 8,125 | 0.00 | — | 78,452 | D | ↗ |
| 2026-02-13 | Ganot Ilan | Director | M-Exempt | D | Restricted Stock Units | 4,861 | 0.00 | — | 9,722 | I | ↗ |
| 2026-02-13 | Cumbo Alexander | Director / Officer | M-Exempt | D | Restricted Stock Units | 30,031 | 0.00 | — | 60,063 | D | ↗ |
| 2026-02-13 | Brooks Gabriel | Officer | M-Exempt | A | Common Stock | 10,937 | 0.00 | — | 95,029 | D | ↗ |
| 2026-02-04 | Tan Kevin | Officer | S-Sale | D | Common Stock | 14,783 | 6.44 | 95.2K | 94,201 | D | ↗ |
| 2026-02-04 | Howton David T | Officer | S-Sale | D | Common Stock | 18,894 | 6.44 | 121.7K | 97,859 | D | ↗ |
| 2026-02-04 | Herzich Paul | Officer | S-Sale | D | Common Stock | 10,905 | 6.44 | 70.2K | 69,067 | D | ↗ |
| 2026-02-04 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 12,348 | 6.44 | 79.5K | 70,327 | D | ↗ |
| 2026-02-04 | Ganot Ilan | Director | S-Sale | D | Common Stock | 7,205 | 6.44 | 46.4K | 25,271 | I | ↗ |
| 2026-02-04 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 48,913 | 6.44 | 315.1K | 222,018 | D | ↗ |
| 2026-02-04 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 12,616 | 6.44 | 81.3K | 84,092 | D | ↗ |
| 2026-02-02 | Tan Kevin | Officer | S-Sale | D | Common Stock | 26,837 | 6.44 | 172.7K | 108,984 | D | ↗ |
| 2026-02-02 | Howton David T | Officer | S-Sale | D | Common Stock | 37,771 | 6.44 | 243.1K | 116,753 | D | ↗ |
| 2026-02-02 | Herzich Paul | Officer | S-Sale | D | Common Stock | 26,250 | 6.44 | 169.0K | 79,972 | D | ↗ |
| 2026-02-02 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 26,535 | 6.44 | 170.8K | 82,675 | D | ↗ |
| 2026-02-02 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 80,258 | 6.44 | 516.6K | 270,931 | D | ↗ |
| 2026-02-02 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 28,335 | 6.44 | 182.4K | 96,708 | D | ↗ |
| 2026-01-31 | Tan Kevin | Officer | M-Exempt | A | Common Stock | 33,075 | 0.00 | — | 135,821 | D | ↗ |
| 2026-01-31 | Howton David T | Officer | M-Exempt | D | Restricted Stock Units | 42,275 | 0.00 | — | 126,825 | D | ↗ |
| 2026-01-31 | Herzich Paul | Officer | M-Exempt | A | Common Stock | 24,675 | 0.00 | — | 106,222 | D | ↗ |
| 2026-01-31 | Hanrahan Jessie | Officer | M-Exempt | D | Restricted Stock Units | 27,625 | 0.00 | — | 82,875 | D | ↗ |
| 2026-01-31 | Ganot Ilan | Director | M-Exempt | D | Restricted Stock Units | 15,000 | 0.00 | — | 45,000 | I | ↗ |
| 2026-01-31 | Cumbo Alexander | Director / Officer | M-Exempt | A | Common Stock | 100,400 | 0.00 | — | 351,189 | D | ↗ |
| 2026-01-31 | Brooks Gabriel | Officer | M-Exempt | A | Common Stock | 28,225 | 0.00 | — | 125,043 | D | ↗ |
| 2026-01-29 | Tan Kevin | Officer | A-Award | A | Restricted Stock Units | 56,647 | 0.00 | — | 56,647 | D | ↗ |
| 2026-01-29 | Howton David T | Officer | A-Award | A | Restricted Stock Units | 105,100 | 0.00 | — | 105,100 | D | ↗ |
| 2026-01-29 | Herzich Paul | Officer | M-Exempt | A | Common Stock | 54,925 | 0.00 | — | 81,547 | D | ↗ |
| 2026-01-29 | Hanrahan Jessie | Officer | A-Award | A | Restricted Stock Units | 54,925 | 0.00 | — | 54,925 | D | ↗ |
| 2026-01-29 | Ganot Ilan | Director | A-Award | A | Employee Stock Option (Right to Buy) | 70,900 | 6.60 | 467.9K | 70,900 | I | ↗ |
| 2026-01-29 | Cumbo Alexander | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 509,850 | 6.60 | 3.37M | 509,850 | D | ↗ |
| 2026-01-29 | Brooks Gabriel | Officer | M-Exempt | D | Performance Stock Units | 58,847 | 0.00 | — | 0 | D | ↗ |
| 2026-01-28 | Ganot Ilan | Director | S-Sale | D | Common Stock | 191 | 6.59 | 1.3K | 17,476 | I | ↗ |
| 2026-01-27 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 3,884 | 0.00 | — | 99,297 | D | ↗ |
| 2026-01-13 | Tan Kevin | Officer | S-Sale | D | Common Stock | 5,704 | 5.27 | 30.1K | 46,100 | D | ↗ |
| 2026-01-09 | Tan Kevin | Officer | M-Exempt | A | Common Stock | 11,250 | 0.00 | — | 51,804 | D | ↗ |
| 2026-01-06 | SMITH IAN F | Director | M-Exempt | D | Restricted Stock Units | 4,573 | 0.00 | — | 0 | D | ↗ |
| 2026-01-05 | Ganot Ilan | Director | S-Sale | D | Common Stock | 1,053 | 5.43 | 5.7K | 17,278 | I | ↗ |
| 2026-01-03 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 2,994 | 0.00 | — | 18,331 | I | ↗ |
| 2026-01-02 | SMITH IAN F | Director | A-Award | A | Restricted Stock Units | 13,761 | 0.00 | — | 13,761 | D | ↗ |
| 2025-12-03 | Howton David T | Officer | S-Sale | D | Common Stock | 4,932 | 5.11 | 25.2K | 32,908 | D | ↗ |
| 2025-12-03 | Herzich Paul | Officer | S-Sale | D | Common Stock | 2,701 | 5.11 | 13.8K | 26,622 | D | ↗ |
| 2025-12-03 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 4,483 | 5.11 | 22.9K | 26,660 | D | ↗ |
| 2025-12-03 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 10,808 | 5.11 | 55.2K | 81,388 | D | ↗ |
| 2025-12-02 | Howton David T | Officer | M-Exempt | A | Common Stock | 13,051 | 0.00 | — | 37,840 | D | ↗ |
| 2025-12-02 | Herzich Paul | Officer | M-Exempt | A | Common Stock | 7,239 | 0.00 | — | 29,323 | D | ↗ |
| 2025-12-02 | Hanrahan Jessie | Officer | M-Exempt | A | Common Stock | 11,862 | 0.00 | — | 31,143 | D | ↗ |
| 2025-12-02 | Cumbo Alexander | Director / Officer | M-Exempt | A | Common Stock | 28,612 | 0.00 | — | 92,196 | D | ↗ |
| 2025-11-10 | Ganot Ilan | Director | S-Sale | D | Common Stock | 3,278 | 4.12 | 13.5K | 95,412 | D | ↗ |
| 2025-10-20 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 2,895 | 5.96 | 17.3K | 33,819 | D | ↗ |
| 2025-10-18 | Brooks Gabriel | Officer | M-Exempt | A | Common Stock | 9,750 | 0.00 | — | 36,714 | D | ↗ |
| 2025-10-06 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 4,573 | 0.00 | — | 126,692 | D | ↗ |
| 2025-08-14 | Tan Kevin | Officer | A-Award | A | Restricted Stock Units | 62,500 | 0.00 | — | 62,500 | D | ↗ |
| 2025-08-14 | Howton David T | Officer | A-Award | A | Restricted Stock Units | 75,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-08-14 | Herzich Paul | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 100,000 | 6.17 | 617.0K | 100,000 | D | ↗ |
| 2025-08-14 | Hanrahan Jessie | Officer | A-Award | A | Restricted Stock Units | 71,250 | 0.00 | — | 71,250 | D | ↗ |
| 2025-08-14 | Ganot Ilan | Director | A-Award | A | Restricted Stock Units | 18,750 | 0.00 | — | 18,750 | I | ↗ |
| 2025-08-14 | Cumbo Alexander | Director / Officer | A-Award | A | Restricted Stock Units | 168,750 | 0.00 | — | 168,750 | D | ↗ |
| 2025-08-14 | Brooks Gabriel | Officer | A-Award | A | Restricted Stock Units | 71,250 | 0.00 | — | 71,250 | D | ↗ |
| 2025-07-06 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 4,573 | 0.00 | — | 122,119 | D | ↗ |
| 2025-06-12 | Sullivan Lynne Marie | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | Stone Adam Leo | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | SMITH IAN F | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | I | ↗ |
| 2025-06-12 | Nagendran Sukumar | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | Keresty Georgia | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | Kahn Clare | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | Ganot Ilan | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-06-12 | Freed Martin I | Director | A-Award | A | Director Stock Option (Right to Buy) | 77,500 | 4.58 | 355.0K | 77,500 | D | ↗ |
| 2025-04-06 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 4,574 | 0.00 | — | 117,546 | D | ↗ |
| 2025-03-11 | Kahn Clare | Director | P-Purchase | A | Common Stock | 1,860 | 5.34 | 9.9K | 2,960 | D | ↗ |
| 2025-02-19 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | P-Purchase | A | Pre-Funded Warrants (Right to Buy) | 3,722,085 | 0.00 | 3.7K | 3,722,085 | I | ↗ |
| 2025-02-19 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | P-Purchase | A | Common Stock | 5,000,000 | 4.03 | 20.15M | 11,833,539 | I | ↗ |
| 2025-02-19 | Bain Capital Life Sciences Investors, LLC | 10% Owner | P-Purchase | A | Pre-Funded Warrant (right to buy) | 6,444,170 | 0.00 | 6.4K | 6,444,170 | I | ↗ |
| 2025-02-18 | Adage Capital Management, L.P. | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value per share | 252,545 | 7.56 | 1.91M | 4,248,084 | I | ↗ |
| 2025-02-14 | Tan Kevin | Officer | S-Sale | D | Common Stock | 3,164 | 3.96 | 12.5K | 32,250 | D | ↗ |
| 2025-02-14 | Howton David T | Officer | S-Sale | D | Common Stock | 5,561 | 3.96 | 22.0K | 24,789 | D | ↗ |
| 2025-02-14 | Herzich Paul | Officer | S-Sale | D | Common Stock | 2,688 | 3.96 | 10.6K | 18,388 | D | ↗ |
| 2025-02-14 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 3,079 | 3.96 | 12.2K | 19,281 | D | ↗ |
| 2025-02-14 | Ganot Ilan | Director | S-Sale | D | Common Stock | 1,711 | 3.96 | 6.8K | 14,839 | I | ↗ |
| 2025-02-14 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 11,365 | 3.96 | 45.0K | 60,717 | D | ↗ |
| 2025-02-14 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 3,256 | 3.96 | 12.9K | 22,812 | D | ↗ |
| 2025-02-13 | Tan Kevin | Officer | M-Exempt | D | Restricted Stock Units | 10,625 | 0.00 | — | 31,875 | D | ↗ |
| 2025-02-13 | Howton David T | Officer | M-Exempt | A | Common Stock | 14,687 | 0.00 | — | 30,350 | D | ↗ |
| 2025-02-13 | Herzich Paul | Officer | M-Exempt | A | Common Stock | 7,187 | 0.00 | — | 21,076 | D | ↗ |
| 2025-02-13 | Hanrahan Jessie | Officer | M-Exempt | A | Common Stock | 8,125 | 0.00 | — | 22,360 | D | ↗ |
| 2025-02-13 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 4,861 | 0.00 | — | 16,550 | I | ↗ |
| 2025-02-13 | Cumbo Alexander | Director / Officer | M-Exempt | A | Common Stock | 30,031 | 0.00 | — | 72,082 | D | ↗ |
| 2025-02-13 | Brooks Gabriel | Officer | M-Exempt | A | Common Stock | 10,937 | 0.00 | — | 26,068 | D | ↗ |
| 2025-01-31 | Tan Kevin | Officer | A-Award | A | Restricted Stock Units | 132,300 | 0.00 | — | 132,300 | D | ↗ |
| 2025-01-31 | Howton David T | Officer | A-Award | A | Restricted Stock Units | 169,100 | 0.00 | — | 169,100 | D | ↗ |
| 2025-01-31 | Herzich Paul | Officer | A-Award | A | Restricted Stock Units | 98,700 | 0.00 | — | 98,700 | D | ↗ |
| 2025-01-31 | Hanrahan Jessie | Officer | A-Award | A | Restricted Stock Units | 110,500 | 0.00 | — | 110,500 | D | ↗ |
| 2025-01-31 | Ganot Ilan | Director | A-Award | A | Restricted Stock Units | 60,000 | 0.00 | — | 60,000 | I | ↗ |
| 2025-01-31 | Cumbo Alexander | Director / Officer | A-Award | A | Restricted Stock Units | 401,600 | 0.00 | — | 401,600 | D | ↗ |
| 2025-01-31 | Brooks Gabriel | Officer | A-Award | A | Restricted Stock Units | 112,900 | 0.00 | — | 112,900 | D | ↗ |
| 2025-01-28 | Ganot Ilan | Director | S-Sale | D | Common Stock | 144 | 3.11 | 447.78 | 11,689 | I | ↗ |
| 2025-01-27 | Ganot Ilan | Director | M-Exempt | D | Restricted Stock Units | 388 | 0.00 | — | 389 | I | ↗ |
| 2025-01-10 | Tan Kevin | Officer | S-Sale | D | Common Stock | 4,073 | 3.89 | 15.8K | 24,789 | D | ↗ |
| 2025-01-09 | Tan Kevin | Officer | M-Exempt | A | Common Stock | 11,250 | 0.00 | — | 28,862 | D | ↗ |
| 2025-01-06 | SMITH IAN F | Director | A-Award | A | Stock Option (Right to Buy) | 22,148 | 4.10 | 90.8K | 22,148 | D | ↗ |
| 2025-01-06 | Ganot Ilan | Director | S-Sale | D | Common Stock | 1,056 | 4.31 | 4.6K | 11,445 | I | ↗ |
| 2025-01-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 3,255 | 0.00 | — | 112,972 | D | ↗ |
| 2025-01-03 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 2,994 | 0.00 | — | 12,501 | I | ↗ |
| 2024-12-03 | Howton David T | Officer | S-Sale | D | Common Stock | 5,072 | 5.60 | 28.4K | 15,663 | D | ↗ |
| 2024-12-03 | Herzich Paul | Officer | S-Sale | D | Common Stock | 2,777 | 5.60 | 15.6K | 12,182 | D | ↗ |
| 2024-12-03 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 4,610 | 5.60 | 25.8K | 14,235 | D | ↗ |
| 2024-12-03 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 11,114 | 5.60 | 62.2K | 38,484 | D | ↗ |
| 2024-12-02 | Howton David T | Officer | M-Exempt | A | Common Stock | 13,051 | 0.00 | — | 20,735 | D | ↗ |
| 2024-12-02 | Herzich Paul | Officer | M-Exempt | D | Restricted Stock Units | 7,239 | 0.00 | — | 14,478 | D | ↗ |
| 2024-12-02 | Hanrahan Jessie | Officer | M-Exempt | D | Restricted Stock Units | 11,862 | 0.00 | — | 23,725 | D | ↗ |
| 2024-12-02 | Cumbo Alexander | Director / Officer | M-Exempt | D | Restricted Stock Units | 28,612 | 0.00 | — | 57,225 | D | ↗ |
| 2024-10-21 | Brooks Gabriel | Officer | S-Sale | D | Common Stock | 2,923 | 6.50 | 19.0K | 10,979 | D | ↗ |
| 2024-10-18 | Brooks Gabriel | Officer | M-Exempt | D | Restricted Stock Units | 9,750 | 0.00 | — | 29,250 | D | ↗ |
| 2024-10-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 3,255 | 0.00 | — | 109,717 | D | ↗ |
| 2024-07-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 3,255 | 0.00 | — | 106,462 | — | ↗ |
| 2024-06-11 | Sullivan Lynne Marie | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | Stone Adam Leo | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | D | ↗ |
| 2024-06-11 | SMITH IAN F | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | I | ↗ |
| 2024-06-11 | Nagendran Sukumar | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | Keresty Georgia | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | Kahn Clare | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | Ganot Ilan | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-11 | Freed Martin I | Director | A-Award | A | Director Stock Option (Right to Buy) | 34,400 | 7.51 | 258.3K | 34,400 | — | ↗ |
| 2024-06-07 | Kahn Clare | Director | P-Purchase | A | Common Stock | 1,100 | 7.67 | 8.4K | 1,100 | — | ↗ |
| 2024-05-02 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 1,553 | 0.00 | — | 9,969 | — | ↗ |
| 2024-04-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 3,256 | 0.00 | — | 103,207 | — | ↗ |
| 2024-02-13 | Tan Kevin | Officer | A-Award | A | Restricted Stock Units | 42,500 | 0.00 | — | 42,500 | — | ↗ |
| 2024-02-13 | Marlowe Jennifer | Officer | A-Award | A | Restricted Stock Units | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2024-02-13 | Howton David T | Officer | A-Award | A | Restricted Stock Units | 58,750 | 0.00 | — | 58,750 | — | ↗ |
| 2024-02-13 | Herzich Paul | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 57,500 | 7.85 | 451.4K | 57,500 | — | ↗ |
| 2024-02-13 | Hanrahan Jessie | Officer | A-Award | A | Restricted Stock Units | 32,500 | 0.00 | — | 32,500 | — | ↗ |
| 2024-02-13 | Ganot Ilan | Director | A-Award | A | Restricted Stock Units | 19,444 | 0.00 | — | 19,444 | — | ↗ |
| 2024-02-13 | Cumbo Alexander | Director / Officer | A-Award | A | Restricted Stock Units | 120,125 | 0.00 | — | 120,125 | — | ↗ |
| 2024-02-13 | Brooks Gabriel | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 87,500 | 7.85 | 686.9K | 87,500 | — | ↗ |
| 2024-01-29 | Ganot Ilan | Director | S-Sale | D | Common Stock | 139 | 7.99 | 1.1K | 8,416 | — | ↗ |
| 2024-01-27 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 3,883 | 0.00 | — | 94,807 | — | ↗ |
| 2024-01-11 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 904,160 | 5.53 | 5.00M | 4,192,216 | — | ↗ |
| 2024-01-11 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | P-Purchase | A | Common Stock | 3,410,713 | 5.53 | 18.86M | 6,833,539 | — | ↗ |
| 2024-01-11 | Koppel Adam | Director / 10% Owner | A-Award | A | Common Stock | 904,160 | 5.53 | 5.00M | 4,034,582 | — | ↗ |
| 2024-01-11 | Bain Capital Life Sciences Investors, LLC | Director / 10% Owner | A-Award | A | Common Stock | 904,160 | 5.53 | 5.00M | 4,034,582 | — | ↗ |
| 2024-01-11 | BCLS II Equity Opportunities GP, LLC | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 904,160 | — | ↗ |
| 2024-01-09 | Tan Kevin | Officer | M-Exempt | D | Restricted Stock Units | 11,250 | 0.00 | — | 33,750 | — | ↗ |
| 2024-01-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 15,570 | 0.00 | — | 99,948 | — | ↗ |
| 2024-01-03 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 2,993 | 0.00 | — | 9,309 | — | ↗ |
| 2023-12-04 | Marlowe Jennifer | Officer | S-Sale | D | Common Stock | 4,890 | 2.77 | 13.5K | 6,998 | — | ↗ |
| 2023-12-04 | Howton David T | Officer | S-Sale | D | Common Stock | 5,367 | 2.78 | 14.9K | 7,684 | — | ↗ |
| 2023-12-04 | Herzich Paul | Officer | S-Sale | D | Common Stock | 2,968 | 2.77 | 8.2K | 4,270 | — | ↗ |
| 2023-12-04 | Hanrahan Jessie | Officer | S-Sale | D | Common Stock | 4,879 | 2.78 | 13.6K | 6,983 | — | ↗ |
| 2023-12-04 | Cumbo Alexander | Director / Officer | S-Sale | D | Common Stock | 11,757 | 2.77 | 32.5K | 17,439 | — | ↗ |
| 2023-12-02 | Marlowe Jennifer | Officer | M-Exempt | D | Restricted Stock Units | 11,888 | 0.00 | — | 35,667 | — | ↗ |
| 2023-12-02 | Howton David T | Officer | M-Exempt | D | Restricted Stock Units | 13,051 | 0.00 | — | 39,154 | — | ↗ |
| 2023-12-02 | Herzich Paul | Officer | M-Exempt | D | Restricted Stock Units | 7,238 | 0.00 | — | 21,717 | — | ↗ |
| 2023-12-02 | Hanrahan Jessie | Officer | M-Exempt | D | Restricted Stock Units | 11,862 | 0.00 | — | 35,587 | — | ↗ |
| 2023-12-02 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 1,583 | 0.00 | — | 90,924 | — | ↗ |
| 2023-12-02 | Cumbo Alexander | Director / Officer | M-Exempt | A | Common Stock | 28,612 | 0.00 | — | 29,196 | — | ↗ |
| 2023-10-18 | Brooks Gabriel | Officer | A-Award | A | Restricted Stock Units | 39,000 | 0.00 | — | 39,000 | — | ↗ |
| 2023-10-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 15,569 | 0.00 | — | 84,378 | — | ↗ |
| 2023-09-02 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 1,583 | 0.00 | — | 89,341 | — | ↗ |
| 2023-07-03 | SMITH IAN F | Director | M-Exempt | A | Common Stock | 15,570 | 0.00 | — | 68,809 | — | ↗ |
| 2023-06-06 | Sullivan Lynne Marie | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Stone Adam Leo | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | SMITH IAN F | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Nagendran Sukumar | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Koppel Adam | Director / 10% Owner | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Keresty Georgia | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Kahn Clare | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Ganot Ilan | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-06 | Freed Martin I | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 6.37 | 61.5K | 9,650 | — | ↗ |
| 2023-06-02 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 1,583 | 0.00 | — | 87,758 | — | ↗ |
| 2023-05-02 | Ganot Ilan | Director | S-Sale | D | Common Stock | 487 | 4.85 | 2.4K | 4,153 | — | ↗ |
| 2023-04-03 | SMITH IAN F | Director | M-Exempt | D | Restricted Stock Units | 15,569 | 0.00 | — | 46,709 | — | ↗ |
| 2023-03-02 | Ganot Ilan | Director | M-Exempt | A | Common Stock | 1,584 | 0.00 | — | 86,175 | — | ↗ |
| 2023-01-27 | Morris Carl Ashley | Officer | M-Exempt | D | Restricted Stock Units | 1,233 | 0.00 | — | 3,700 | — | ↗ |
| 2023-01-27 | Ganot Ilan | Director | S-Sale | D | Common Stock | 1,382 | 7.49 | 10.4K | 84,591 | — | ↗ |
| 2023-01-09 | Tan Kevin | Officer | A-Award | A | Restricted Stock Units | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2023-01-03 | SMITH IAN F | Director | M-Exempt | A | Stock Option (Right to Buy) | 70,796 | 0.00 | — | 70,796 | — | ↗ |
| 2023-01-03 | Morris Carl Ashley | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 95,110 | 0.00 | — | 95,110 | — | ↗ |
| 2023-01-03 | Ganot Ilan | Director | A-Award | A | Employee Stock Option (Right to Buy) | 23,950 | 0.00 | — | 23,950 | — | ↗ |
| 2022-12-13 | Sullivan Lynne Marie | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
| 2022-12-13 | Stone Adam Leo | Director | A-Award | A | Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
| 2022-12-13 | SMITH IAN F | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
| 2022-12-13 | RA CAPITAL MANAGEMENT, L.P. | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
| 2022-12-13 | PERCEPTIVE ADVISORS LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 9,650 | 6.47 | 62.4K | 9,650 | — | ↗ |
| 2022-12-13 | Nagendran Sukumar | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
| 2022-12-13 | Koppel Adam | Director | A-Award | A | Director Stock Option (Right to Buy) | 9,650 | 0.00 | — | 9,650 | — | ↗ |
Executive team
Top executives
Shares Outstanding
77.91M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Alexander Cumbo, President and Chief Executive Officer | 651.0K | 449.2K | 2.32M | 1.79M | — | 12.6K | 5.22M | 78.70% | ↗ |
| 2 | 2025 | David Tyronne Howton, Chief Operating Officer and Secretary | 513.4K | 265.7K | 1.00M | 796.6K | — | 12.6K | 2.59M | 69.42% | ↗ |
| 3 | 2025 | Gabriel Brooks, M.D., Chief Medical Officer | 502.2K | 259.9K | 798.6K | 756.8K | — | 10.7K | 2.33M | 66.81% | ↗ |
| 4 | 2024 | Alexander Cumbo, President and Chief Executive Officer | 608.4K | 334.6K | 2.22M | 1.70M | — | 12.4K | 4.87M | 80.38% | ↗ |
| 5 | 2024 | David Tyronne Howton, Chief Operating Officer and Secretary | 473.2K | 189.3K | 1.06M | 831.1K | — | 12.4K | 2.56M | 73.67% | ↗ |
| 6 | 2024 | Gabriel Brooks, M.D., Chief Medical Officer | 468.0K | 187.2K | 785.4K | 618.9K | — | 11.9K | 2.07M | 67.79% | ↗ |
| 7 | 2023 | Carl Morris, Ph.D., Former Chief Scientific Officer, Neuromuscular | 233.2K | 66.1K | 346.9K | 519.8K | — | 393.5K | 1.56M | 55.58% | ↗ |
| 8 | 2023 | Kevin Tan, Chief Financial Officer | 416.1K | 170.0K | 270.0K | 478.3K | — | 11.9K | 1.35M | 55.58% | ↗ |
| 9 | 2023 | Alexander Cumbo, President and Chief Executive Officer | 585.0K | 321.8K | — | — | — | 11.9K | 918.6K | 0.00% | ↗ |
| 10 | 2023 | David Tyronne Howton, Chief Operating Officer and Secretary | 455.0K | 182.0K | — | — | — | 11.9K | 648.9K | 0.00% | ↗ |
| 11 | 2023 | David Tyronne Howton, Chief Operating Officer, General Counsel and Secretary | 455.0K | 182.0K | — | — | — | 11.9K | 648.9K | 0.00% | ↗ |
| 12 | 2022 | Ilan Ganot, Former President and Chief Executive Officer | 532.6K | 318.3K | 306.2K | 536.1K | — | 512.4K | 2.21M | 38.19% | ↗ |
| 13 | 2022 | Alexander Cumbo, President and Chief Executive Officer | 45.5K | — | 774.8K | 1.38M | — | — | 2.20M | 97.93% | ↗ |
| 14 | 2022 | Erin Powers Brennan, Former Chief Legal Officer and Secretary | 430.5K | 238.3K | 163.0K | 247.3K | — | 260.7K | 1.34M | 30.62% | ↗ |
| 15 | 2022 | David Tyronne Howton, Chief Administrative Officer and Secretary | 35.0K | — | 353.4K | 629.4K | — | — | 1.02M | 96.56% | ↗ |
| 16 | 2022 | David Tyronne Howton, Chief Operating Officer, General Counsel and Secretary | 35.0K | — | 353.4K | 629.4K | — | — | 1.02M | 96.56% | ↗ |
| 17 | 2022 | Carl Morris, Chief Scientific Officer | 430.5K | 66.1K | 83.6K | 288.2K | — | 5.3K | 873.7K | 42.55% | ↗ |
| 18 | 2022 | Carl Morris, Ph.D., Former Chief Scientific Officer, Neuromuscular | 430.5K | 66.1K | 83.6K | 288.2K | — | 5.3K | 873.7K | 42.55% | ↗ |
| 19 | 2021 | Ilan Ganot, President and Chief Executive Officer | 551.1K | 187.9K | — | 2.54M | — | 10.0K | 3.29M | 77.26% | ↗ |
| 20 | 2021 | Ilan Ganot, Former President and Chief Executive Officer | 551.1K | 187.9K | — | 2.54M | — | 10.0K | 3.29M | 77.26% | ↗ |
| 21 | 2021 | Erin Powers Brennan, Former Chief Legal Officer and Secretary | 341.7K | 145.7K | — | 2.38M | — | 8.6K | 2.88M | 82.77% | ↗ |
| 22 | 2021 | Erin Powers Brennan, Chief Legal Officer | 341.7K | 145.7K | — | 2.38M | — | 8.6K | 2.88M | 82.77% | ↗ |
| 23 | 2021 | Joel Schneider, Ph.D., Chief Operating Officer | 423.3K | 118.3K | — | 1.16M | — | 6.1K | 1.70M | 67.83% | ↗ |
| 24 | 2020 | Ilan Ganot, President and Chief Executive Officer | 535.0K | 294.3K | 246.4K | 405.4K | — | — | 1.48M | 44.01% | ↗ |
| 25 | 2020 | Carl Morris, Ph.D., Chief Scientific Officer | 391.0K | 156.4K | 542.6K | 134.2K | — | — | 1.22M | 55.28% | ↗ |
| 26 | 2020 | Jennifer Ziolkowski, Chief Financial Officer | 391.0K | 156.4K | 542.6K | 134.2K | — | — | 1.22M | 55.28% | ↗ |
| 27 | 2019 | Ilan Ganot, President and Chief Executive Officer | 520.0K | 193.1K | — | 2.62M | — | — | 3.34M | 78.63% | ↗ |
| 28 | 2019 | Jorge Quiroz, M.D., Former Chief Medical Officer | 412.5K | 113.4K | — | 1.02M | — | — | 1.54M | 65.88% | ↗ |
| 29 | 2019 | Alvaro Amorrortu, Former Chief Operating Officer | 400.0K | 108.0K | — | 1.02M | — | — | 1.52M | 66.65% | ↗ |
| 30 | 2018 | Ilan Ganot, President and Chief Executive Officer | 450.0K | 247.5K | — | 5.29M | — | — | 5.98M | 88.34% | ↗ |
| 31 | 2018 | Carl Morris, Ph.D. Chief Scientific Officer | 320.0K | 128.0K | — | 3.60M | — | — | 4.05M | 88.94% | ↗ |
| 32 | 2018 | Alvaro Amorrortu, Former Chief Operating Officer | 330.0K | 132.0K | — | 2.38M | — | — | 2.84M | 83.75% | ↗ |
| 33 | 2018 | Alvaro Amorrortu, Chief Operating Officer | 330.0K | 132.0K | — | 2.38M | — | — | 2.84M | 83.75% | ↗ |
| 34 | 2017 | Ilan Ganot, President and Chief Executive Officer | 400.0K | 200.0K | — | — | — | — | 600.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alexander G. Cumbo | President, Chief Executive Officer & Director | 1M | male |
| David Tyronne Howton Jr. | Chief Operating Officer & Secretary | 791.7K | male |
| Gabriel Brooks | Chief Medical Officer | 772.7K | — |
| Kevin Tan | Chief Financial Officer & Treasurer | 607.2K | male |
| Ian F. Smith | Executive Chair | 75.0K | male |
| Ilan Ganot | Co-founder, Strategic Advisor to the Chief Executive Officer & Director | 40.0K | male |
| Jessie Hanrahan | Chief Regulatory & Preclinical Operations Officer | — | — |
| Annie Ganot | Co-Founder & Vice President of Patient Advocacy | — | female |
| Nicole Anderson | Senior Director of Investor Relations & Corporate Communications | — | female |
| Paul Herzich | Chief Technology Officer | — | male |
| Shuli Kulak | Head of Corporate Strategy & Business Development | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SLDB
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
